Tuico, Nestor O.
HRN: 18-22-29 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/23/2022
07/30/2022
IV
300mg
Q6
Sepsis; Decubitus Ulcer
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Dose Wrong Dose
Overall appropriateness: No Wrong Dose